Therefore, the CaM-CaMKII-CREB signaling pathway, which regulates Ca2+ concentration in neuronal cells, plays an important role in synaptic degeneration and memory loss in AD, and it is also a potential therapeutic target for treating AD [19]. Here, CREB1 is linked to Alzheimer disease.